'Immunosuppressive drugs' presentation slideshows

Prevention of Surgical Site Infections

Prevention of Surgical Site Infections. William A. Rutala, Ph.D., M.P.H. UNC Health Care System and UNC School of Medicine, Chapel Hill, NC. Disclosure.

3.24k views • 75 slides

T-Cells NK

T-Cells NK . Feb 13, 2006. T-cells. Antigens that are transported by dendritic cells to lymph nodes are recognized by naive T lymphocytes that recirculate through these lymph nodes.

986 views • 61 slides

Medicare for People with End-Stage Renal Disease or a Disability

Module 6. Medicare for People with End-Stage Renal Disease or a Disability. Lesson A Medicare for People with End-Stage Renal Disease. Lesson Topics. Overview Eligibility and enrollment Coverage Health plan options Information sources. Lesson Topics. Overview Eligibility and enrollment

724 views • 60 slides

Tuberculosis Today

992 views • 57 slides

INTRODUCTION TO MEDICAL MYCOLOGY

INTRODUCTION TO MEDICAL MYCOLOGY. Fungi (yeast& molds) are eukaryotic organisms whereas bacteria are prokaryotic , they differ regarding;. Size-diameter 4 um-------1um Nucleus. Cytoplasm Cell membrane, Sterol---absent in bacteria Cell wall,

1.6k views • 39 slides

General Food Safety

General Food Safety . Who might be immuno-compromised or have a weakened immune system?

574 views • 38 slides

Screening of Latent Tuberculosis before treatment with TNF ? blockers

Screening of Latent Tuberculosis before treatment with TNF ? blockers. Ori Elkayam M.D Tel Aviv Medical Center. Guidelines of the Israeli association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blocker. Screening includes :

941 views • 34 slides

Immunity, Hypersensitivity, Allergy, and Autoimmune Diseases

Chapter 5. Immunity, Hypersensitivity, Allergy, and Autoimmune Diseases. Learning Objectives. Differentiate cell-mediated versus humoral immunity Compare immunity and hypersensitivity List and differentiate five classes of antibodies Hypersensitivity reaction Describe pathogenesis

1.07k views • 33 slides

Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD

Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD. Raymond Cross, M.D., M.S., AGAF Associate Professor of Medicine Director of the Inflammatory Bowel Disease Program University of Maryland School of Medicine Co-Director, Digestive Health Center

481 views • 29 slides

A Vocabulary Review Activity

A Vocabulary Review Activity. Setup Directions:. Type a vocabulary word on each of the following 10 slides in the subtitle textbox. When complete, run the show by pressing F5 on the keyboard. One student stands with back to this presentation.

406 views • 28 slides

Anti-Inflammatory & Immunosuppressive Drugs 2

Anti-Inflammatory & Immunosuppressive Drugs 2. I-3 Fall 2011 Susan Masters, Ph.D. The Inflammatory Cascade. Immunophilin ligands, mycophenolate mofetil, DMARDs, anti-TNF, etc. Perceived threat. Infection. Tissue injury. Adaptive immune system. Innate immune system. Anti-gout drugs.

620 views • 20 slides

Medicare Drug Coverage Under Part A, Part B, and Part D

Medicare Drug Coverage Under Part A, Part B, and Part D. Module 8. Session Topics. Overview Drug coverage under Medicare Part A Drug coverage under Medicare Part B Medicare prescription drug coverage Part D Medicare parts A/B/D coordination Information sources. Medicare Parts A, B, and D.

404 views • 20 slides

M. Ulanova, S. Gravelle, N. Hawdon, S. Malik, D. Vergidis, and W. McCready

Risk of invasive H. influenzae disease in patients with chronic renal failure: a call for vaccination?. M. Ulanova, S. Gravelle, N. Hawdon, S. Malik, D. Vergidis, and W. McCready. Lake Superior. Secondary Immunodeficiency States.

317 views • 20 slides

313 views • 16 slides

New Strategic Focus

255 views • 16 slides

Update on Penn Pharma

Update on Penn Pharma. John Roberts, Commercial Director December 2012. The Business. Penn provides an integrated range of services to an international client base. Pharmaceutical Development Manufacturing & Packing Support Services

239 views • 9 slides

Systemic Lupus Erythematosus Treatment Market Opportunity Analysis 2018-2026

Systemic Lupus Erythematosus (SLE) is chronic autoimmune disorder. It is characterized by excess production of the antibodies that attacks body’s own cells and vital organs. Various symptoms associated with the disease includes joint pain, swelling, rashes over face (butterfly rash) and other body area, severe fatigue, hair loss, anemia, and Raynaud’s phenomenon etc. SLE can also affect vital body organs such as heart, kidney, lungs, and behavioral changes. Exact causes of the disease is unknown, however, hereditary and environmental factors could be lead to SLE.

110 views • 9 slides

Results

A case of upregulated Cyclosporin-A catabolism in a HIV-1 + /HCV + hemophiliac after liver transplantation and Efavirenz treatment Canbay 1 , R. Gieseler 2 , K. Radecke 1 , M. Kullmer 1 , B. Ross 1 , C. Valentin-Gamazo 3 , U. Treichel 1 , and G. Gerken 1

117 views • 1 slides

Figure 1 Schematic of mechanisms of action of immunosuppressive drugs

1k views • 1 slides

Table 1 Gene polymorphisms and their effect on protein activity and clinical response

Table 1 Gene polymorphisms and their effect on protein activity and clinical response. van Gelder, T. et al. (2014) Pharmacogenetics and immunosuppressive drugs in solid organ transplantation Nat. Rev. Nephrol. doi:10.1038/nrneph.2014.172.

84 views • 1 slides